ACLS
Axcelis Technologies, Inc.
ACLS's outlook is improving, though it still trails on the overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over ACLS overall, supported by stronger valuation and stronger fundamentals.
ACLS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
ACLS's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
ACLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $48.20 | -55% |
| Forward | 18x | $108 | — |
| Fair | 22x | $73.95 | -32% |
| Current | 32x | $108 | — |
| Expensive | 34x | $113 | +4.9% |
Historical ranges are pointers, not guarantees.
ACLS's PE is in its expensive range at 32x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over ACLS in the historical PE scenario, which offers more potential upside but is not a forecast.
ACLS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for ACLS, with profitability improving.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.
ACLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.05 | +80% |
| Q3 2026 | $3.37 | -20% |
| Q2 2026 | $2.99 | -39% |
| Q1 2026 | $3.22 | -41% |
| Q4 2025 | $3.80 | -38% |
| Q3 2025 | $4.23 | -37% |
| Q2 2025 | $4.89 | -33% |
| Q1 2025 | $5.46 | -28% |
| Q4 2024 | $6.15 | -17% |
ACLS's earnings per share have fallen from their peak: $3.37 over the past year, against $7.57 in early 2024.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over ACLS on earnings, with more consistent year-over-year improvement.
ACLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $237.8M | +11% |
| Q2 2026 | $215.2M | +11% |
| Q1 2026 | $199M | +3.3% |
| Q4 2025 | $238.3M | -5.6% |
| Q3 2025 | $213.6M | -17% |
| Q2 2025 | $194.5M | -24% |
| Q1 2025 | $192.6M | -24% |
| Q4 2024 | $252.4M | -19% |
ACLS's revenue is recovering but still below its 2023 peak: $238M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -0.2 points |
| Q2 2026 | 9.4% | -5.5 points |
| Q1 2026 | 4% | -11 points |
| Q4 2025 | 15% | -6.4 points |
| Q3 2025 | 12% | -6.6 points |
| Q2 2025 | 15% | -5.7 points |
| Q1 2025 | 15% | -7.3 points |
| Q4 2024 | 22% | -3.9 points |
ACLS's operating margin was 12% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over ACLS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over ACLS on profitability, with a higher operating margin.
ACLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.7M | -13% |
| Q2 2026 | $14.8M | -61% |
| Q1 2026 | $16.3M | -53% |
| Q4 2025 | -$8.9M | -210% |
| Q3 2025 | $43.3M | +3.6% |
| Q2 2025 | $37.7M | -0.8% |
| Q1 2025 | $34.8M | -14% |
| Q4 2024 | $8.1M | -85% |
ACLS still generates free cash flow, though less than at its 2022 peak: $60M over the past year.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over ACLS on cash flow, with more consistent year-over-year improvement.
ACLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -29K shares |
| 1 year | -1.1% | -345K shares |
| 3 years | -6.2% | -2.1M shares |
| 5 years | -8.8% | -3M shares |
| Available history | -8% | -2.7M shares |
ACLS has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $25.2M |
| Q3 2025 | $32.3M |
| Q2 2025 | $45.3M |
| Q1 2025 | $18.2M |
| Q4 2024 | $15.1M |
| Q3 2024 | $15.4M |
| Q2 2024 | $15M |
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
ACLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
ACLS has the edge over PLTR on leverage, with a lower net debt burden relative to earnings.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has more cash than debt.
ACLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 23.9 | Neutral |
ACLS's weekly RSI is 44 (neutral) and its Stochastic is 24 (neutral).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
ACLS PE vs Technology Sector
| Metric | ACLS | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 15% above |
| PE % | 82 | 35 | 47 pts above |
ACLS has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
ACLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $116.0 | 6.8% below |
| 20 week MA | $123.9 | 13% below |
| 50 week MA | $117.7 | 8.2% below |
| 100 week MA | $93.6 | 15% above |
| 200 week MA | $110.6 | 2.3% below |
ACLS's trend is mixed: it's above one of its five weekly moving averages, and 2.3% below its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over ACLS on trend strength, trading above more of its moving averages.
ACLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.2 | $29.2 | +21% |
| 2021 | $29.2 | $68.1 | +133% |
| 2022 | $68.1 | $80.3 | +18% |
| 2023 | $80.3 | $129.7 | +62% |
| 2024 | $129.7 | $71.2 | -45% |
| 2025 | $71.2 | $82.6 | +16% |
| 2026 YTD | $82.6 | $108.1 | +31% |
ACLS has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.